Ignite Creation Date:
2025-12-25 @ 4:51 AM
Ignite Modification Date:
2026-03-04 @ 9:36 PM
Study NCT ID:
NCT02481518
Status:
COMPLETED
Last Update Posted:
2019-08-20
First Post:
2015-05-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Preloading Magnesium Attenuate Cisplatin-induced Nephrotoxicity
Sponsor:
Mahidol University
Organization:
Study Overview
Official Title:
Preloading Magnesium Attenuate Cisplatin-induced Nephrotoxicity
Status:
COMPLETED
Status Verified Date:
2019-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PRAGMATIC
Brief Summary:
The purpose of this study is to determine whether magnesium preloading reduce incident of cisplatin induced acute kidney injury in head and neck cancer who receiving low dose cisplatin (40 mg/m2 weekly for 7 weeks).
Detailed Description:
Randomized controlled trial comparing efficacy of magnesium preloading versus normal saline for prevention of acute and chronic nephrotoxicity of cisplatin.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: